Background and the purpose of the study: Diclofenac sodium is a non-steroidal anti-inflammatory agent with a short biological half-life (1-2 hr) and requires multiple dosing. This research was carried out to develop and optimize diclofenac sodium loaded alginate-PVP K 30 microbeads to eliminate the need for multiple dosing and adverse effects. Methods: Diclofenac sodium loaded alginate-PVP K 30 microbeads were prepared by ionotropic gelation. Particle size, drug release, swelling, FTIR and SEM analyses were performed. Results: Optimized microbeads showed particle size of 0.589 ± 0.054 to 0.620 ± 0.067 mm, and drug entrapment efficiency of 97.88 ± 2.86 to 98.60 ± 3.55 %. The in vitro drug release from microbeads was sustained over 10 hrs and followed controlled-release pattern. FTIR analysis indicated the possibility of intermolecular hydrogen bonding interactions, i.e., -OH…O=C in microbeads. Conclusion: Microbeads for oral controlled delivery of diclofenac sodium were successfully developed by ionotropic gelation.
INTRODUCTION
Alginate, the monovalent form of alginic acid, belong to the family of linear copolymers composed of β-Dmannuronic acid monomers (M), regions of ∞-Lguluronic acid residues (G), and regions of interspersed M and G units (1) . It is used as matrix material in various formulations due to its hydrogel-forming properties (2) . Alginates undergo gelation due to ionic interaction between carboxylic acid groups located on polymer backbone and these cations like Ca 2+ , Al 3+ , etc (3) (4) . Various drugs have been successfully incorporated in alginate hydrogels and have exhibited different drug release profiles (1, (4) (5) (6) . Diclofenac sodium (DS) is a non-steroidal antiinflammatory agent widely used as analgesic (7) . Its biological half-life is 1-2 hr (2) and requires multiple dosing to maintain therapeutic concentration in blood. Hence, the controlled release systems of DS can eliminate the need for multiple dosing and adverse effects. Several investigations on formulation of DSloaded alginate-based microparticles/beads using different polymer-blend have been reported (7) (8) (9) (10) . However, no attempt has been taken to formulate DS-loaded bead system using alginate-polyvinyl pyrrolidone (PVP) blend. Therefore in the present investigation, an attempt was made to develope and optimize DS-loaded alginate-PVP K 30 microbeads. The effects of ratios of sodium alginate to PVP K 30 and CaCl 2 (cross-linker) concentrations on drug entrapment and release were analyzed using central composite design (CCD).
MATERIAL AND METHODS

Materials
DS (Techno Remedies, India), calcium chloride, sodium alginate and PVP K 30 (Loba Chemie, India) were used in this study. Other chemicals used were of analytical grades.
Microbead preparation DS-loaded alginate-PVP K 30 microbeads were prepared by ionotropic gelation (2) . Sodium alginate and PVP K 30 aqueous solutions were mixed together. Then, DS was added to the mixture and homogenized (for 10 min, 1000 rpm). The resulting mixture (drug : polymer = 1:2) was dropped into CaCl 2 solution via 26-gauge needle. After 15 min, beads were collected by decantation, washed repeatedly with deionized water and dried at 45°C for 12 hrs. DS-loaded alginate microbeads were prepared by the same method but without addition of PVP K 30.
Experimental design
The experimental factors were selected as polymerblend ratio and CaCl 2 concentration; while responses were Drug Entrapment Efficiency (DEE) and drug release after 10 hrs (R 10hr ). The factors and levels are reported in table 1. The quadratic model was used to evaluate responses using Design-Expert ® Software according to CCD (11):
where, Y = response; b 0 = intercept, and b 1 -b 5 = regression coefficients. X 1 and X 2 = individual effects; X 1 2 and X 2 2 = quadratic effects; X 1 X 2 = interaction effect.
Determination of the Drug
Entrapment Efficiency (DEE) Drug-loaded microbeads (100 mg) were dispersed in 500 ml of phosphate buffer of pH 7.4 and sonicated for 10 min. The mixture was stirred at 1000 rpm for 4 hrs and filtered through Whatman ® filter paper. Drug contents in filtrates were determined using UV-VIS spectrophotometer (Shimadzu, Japan) at 276 nm wavelength. The DEE of beads was calculated using following formula:
Theoretical drug content
Particle size and morphological analyses Microbeads were measured for particle size using optical microscope (Olympus, Japan). Surface morphology was examined by scanning electron microscopy (SEM) (Hitachi, Japan).
Fourier transform infrared (FTIR) spectroscopy
Spectra were obtained by FTIR spectrophotometer (Perkin-Elmer, USA) in the wavelength region of 4000-400 cm -1 using pellets of KBr.
In vitro drug release studies Dissolution apparatus USP (Campbell Electronics, India) was employed to study the drug release at 37°C 50 rpm. Microbeads containing DS equivalent to 100 mg were taken in 900 ml of dissolution medium (0.1 N HCl of pH 1.2 for 2 hrs and phosphate buffer of pH 7.4 for next hrs). Drug content in samples were measured using UV-VIS spectrophotometer (Shimadzu, Japan) at 276 nm wavelength.
Swelling evaluation
Microbeads (100 mg) were soaked in phosphate buffer of pH 7.4 and 0.1 N HCl of pH 1.2. Swelled microbeads were removed and weighed. Swelling indexes were determined using the formula:
Swelling index = Weight of swelled microbeads Dry weight ×100 (3) Dry weight RESULTS AND DISCUSSION DS-loaded alginate-PVP K 30 microbeads were prepared by ionotropic gelation according to CCD (Table 2 ). Quadratic models were selected as betterfit models due to smaller PRESS, and insignificant lack of fit ( Table 3) . Results of ANOVA indicated all models were significant (Table 4) . After eliminating non-significant (p > 0.05) terms, the models became:
Three-dimensional response surface ( Fig. 1) , and contour plots ( Fig. 2 ) demonstrate changes in DEE, and R 10hr due to variation of factors. For optimization, numerical analysis was performed by restricting desirable ranges to 95 ≤ DEE ≤ 100 %, and 60 ≤ R 10hr ≤ 65 %. The optimized microbeads were formulated and evaluated (Table 5 ). Models to produce optimized responses were well fitted (R 2 = 0.9912 for DEE, and 0.9967 for R 10hr ). Optimized microbeads showed DEE of 97.88 ± 2.86 to 98.60 ± 3.55 %. Among DS-loaded alginate microbeads, highest DEE of 85.77 ± 2.92 % was observed in the case of S-3 ( Table 6 ). The particle sizes of alginate-PVP K 30 microbeads decreased by increase in the amount of incorporated PVP K 30 (due to decrease in viscosity and droplet sizes of polymer solution), and the CaCl 2 concentration (due to high degree cross-linking) ( Table 7 ). The surface morphology of optimized beads was visualized by SEM, which showed rough surface (Fig. 3) . In FTIR spectra, incorporation of DS in alginate showed characteristic peaks of DS, and alginate (Fig. 4) . However, in DS-loaded alginate-PVP K 30 microbeads, two characteristic shifts for C=O stretching of PVP, and -OH groups of alginate compared to pure component (Fig. 4) appeared which strongly supports the idea of an intermolecular hydrogen-bonding between C=O groups of PVP, and -OH groups of alginate in alginate-PVP K 30 microbeads. Microbeads were found to release negligible amounts of DS in acidic medium which probably could be the surface adhered drug. Alginate-PVP K 30 microbeads showed prolonged drug release over 10 hrs (Figs. 5and 6 alginate microbeads showed high percent of DS release (Fig. 6) . The drug release from optimized microbeads was evaluated using various kinetic models, and it was found that the drug release followed zero-order model (Table 8) , indicating controlled-release pattern. The Korsmeyer-Peppas model was employed to distinguish Fickian-release when n ≤ 0.43 and case-II transport when n ≥ 0.85 (in Korsmeyer-Peppas Model, n is diffusional exponent) (12, 13) . The values of n ranged between 0.9632 to 0.9950 (Table 8) , indicating the drug release followed case-II transport. The swelling of optimized DS-loaded alginate-PVP K 30 microbeads was lower in acidic medium (pH 1.2) in comparison with that of alkaline medium (pH 7.4) (Fig. 7) . Maximum swelling was noticed after 2-3 hrs in alkaline pH after which, erosion and dissolution took place. The swelling of optimized microbeads in alkaline pH could be explained by the exchange of ions between the calcium ion of microbeads and the sodium ions present in phosphate buffer, under influence of calcium-sequestrant phosphate ions, which could result in disaggregation of alginate-PVP K 30-matrix structure leading to matrix erosion and dissolution of swollen microbeads (14, 15) . Table 6 . Processing parameters and responses of plain alginate microbeads containing diclofenac sodium. 
CONCLUSION
The optimized formulation of alginate-PVP K 30
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